The Role of Ipilimumab in Bladder Cancer

Matthew D. Galsky, MD, discusses the potential role of ipilimumab for the treatment of advanced bladder cancer.

Matthew D. Galsky, MD, assistant professor of medicine, Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, director, Genitourinary Medical Oncology, Tisch Cancer Institute at Mount Sinai Medical Center, discusses the potential role of ipilimumab for the treatment of advanced bladder cancer.

Clinical Pearls:

  • Researchers have found that drugs such as ipilimumab are achieving the goal of recruiting immune cells to the tumors in patients with early-stage bladder cancer
  • However, this has yet to be translated into the treatment of patients with advanced bladder cancer